0001753926-24-000372.txt : 20240223
0001753926-24-000372.hdr.sgml : 20240223
20240223171256
ACCESSION NUMBER: 0001753926-24-000372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedberg Ezra M
CENTRAL INDEX KEY: 0001679440
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41964
FILM NUMBER: 24672545
MAIL ADDRESS:
STREET 1: 1000 MARINA BOULEVARD
STREET 2: SUITE 250
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chromocell Therapeutics Corp
CENTRAL INDEX KEY: 0001919246
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863335449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
BUSINESS PHONE: 9176446313
MAIL ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
4
1
ownership.xml
X0508
4
2024-02-21
0
0001919246
Chromocell Therapeutics Corp
CHRO
0001679440
Friedberg Ezra M
C/O CHROMOCELL THERAPEUTICS CORPORATION
4400 ROUTE 9 SOUTH, SUITE 1000
FREEHOLD
NJ
07728
1
0
0
0
0
Common Stock
2024-02-21
4
M
0
13649
4.8
A
513727
I
Balmoral Financial Group LLC
Common Stock
2024-02-21
4
M
0
6992
4.8
A
520719
I
Balmoral Financial Group LLC
Secured Convertible Promissory Note
4.80
2024-02-21
4
C
0
65513.61
D
2024-02-21
2024-02-29
Common Stock
13649
0
I
Balmoral Financial Group LLC
Secured Convertible Promissory Note
4.80
2024-02-21
4
C
0
33136.00
D
2024-02-21
2024-03-01
Common Stock
6992
0
I
Balmoral Financial Group LLC
The securities are held by Balmoral Financial Group LLC ("Balmoral"). The Reporting Person serves as a manager of Balmoral, which also manages a retirement account for the Reporting Person, and, accordingly, the Reporting Person may also be deemed to beneficially own the shares of common stock held by Balmoral (or managed by Balmoral, in respect of the retirement account).
Represents $65,513.61 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 13,649 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
Represents $33,136.00 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due March 1, 2024, which automatically converted into 6,992 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, including an additional 88 shares of common stock issued as consideration for this senior secured convertible promissory note.
/s/ Ezra Friedberg
2024-02-23